WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL), ahead of the American Association for Cancer Research® (AACR) Annual Meeting in Chicago, IL, has ...
BOSTON--(BUSINESS WIRE)-- Charles River Development, a State Street Company, announced today the expansion of its relationship with T. Rowe Price through the migration to the SaaS-deployed Charles ...
Charles River Laboratories International, Inc. (NYSE: CRL) and The Francis Crick Institute (Crick) today announced a new collaboration around Antibody-Drug Conjugate (ADC) drug discovery and ...
BOSTON--(BUSINESS WIRE)-- Charles River Development, a State Street company, today announced plans to expand its support of private market assets within the unified managed accounts (UMA) capabilities ...
BOSTON--(BUSINESS WIRE)--Charles River Development, a State Street Company, announced today that Operadora de Fondos Banorte, SA de CV, SOFI, Grupo Financiero Banorte ("BANORTE"), one of Mexico’s ...
StockStory.org on MSN
A look back at drug development inputs & services stocks’ Q4 earnings: Charles River Laboratories (NYSE:CRL) vs the rest of the pack
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...
BOSTON--(BUSINESS WIRE)--Charles River Development, a State Street Company, announced today that T. Rowe Price will transition to Charles River’s cloud-based technology platform. T. Rowe Price will ...
State Street Company Charles River Development has launched Tailored Portfolio Solutions (TPS), an offering that enables both wealth managers and asset managers to provide customised portfolios at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results